Aseanostatin P1 | CAS# 2724-57-4 | Myeloperoxidase Release Inhibitor

MedKoo Cat#: 573286 | Name: Aseanostatin P1

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Aseanostatin P1 is a fatty acid which inhibits myeloperoxidase (MPO) release from human polymorphonuclear leukocytes.

Chemical Structure

Aseanostatin P1

CAS#2724-57-4

Theoretical Analysis

MedKoo Cat#: 573286

Name: Aseanostatin P1

CAS#: 2724-57-4

Chemical Formula: C14H28O2

Exact Mass: 228.2089

Molecular Weight: 228.38

Elemental Analysis: C, 73.63; H, 12.36; O, 14.01

Price and Availability

Size	Price	Availability	Quantity
5mg	USD 315.00	2 Weeks
10mg	USD 550.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

12-Methyltridecanoic acid; Aseanostatin P1; FA 14:0; iso-14:0; iso-C14:0; 12-MTA

IUPAC/Chemical Name

Tridecanoic acid, 12-methyl-

InChi Key

YYVJAABUJYRQJO-UHFFFAOYSA-N

InChi Code

1S/C14H28O2/c1-13(2)11-9-7-5-3-4-6-8-10-12-14(15)16/h13H,3-12H2,1-2H3,(H,15,16)

SMILES Code

CC(C)CCCCCCCCCCC(=O)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 228.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Kitahara T, Aono S, Mori K. Synthesis of both the enantiomers of aseanostatin P5 (sarcinic acid), an inhibitor of myeloperoxidase release, and four diastereomers of aggreceride A, a platelet aggregation inhibitor. Biosci Biotechnol Biochem. 1995 Jan;59(1):78-82. doi: 10.1271/bbb.59.78. PMID: 7765980. 2: Masuda K, Suzuki K, Ishida-Okawara A, Mizuno S, Hotta K, Miyadoh S, Hara O, Koyama M. Pyrrolomycin group antibiotics inhibit substance P-induced release of myeloperoxidase from human polymorphonuclear leukocytes. J Antibiot (Tokyo). 1991 May;44(5):533-40. doi: 10.7164/antibiotics.44.533. PMID: 1712007. 3: Ishida-Okawara A, Kimoto Y, Watanabe K, Tokuda K, Shibata M, Masuda K, Takano Y, Kawaguchi K, Akagawa H, Nilubol N, et al. Purification and characterization of aseanostatins: actinomycete-derived fatty acid inhibitors to myeloperoxidase release from human polymorphonuclear leukocytes. J Antibiot (Tokyo). 1991 May;44(5):524-32. doi: 10.7164/antibiotics.44.524. PMID: 1648056. 4: Colosimo DA, Kohn JA, Luo PM, Piscotta FJ, Han SM, Pickard AJ, Rao A, Cross JR, Cohen LJ, Brady SF. Mapping Interactions of Microbial Metabolites with Human G-Protein-Coupled Receptors. Cell Host Microbe. 2019 Aug 14;26(2):273-282.e7. doi: 10.1016/j.chom.2019.07.002. Epub 2019 Aug 1. PMID: 31378678; PMCID: PMC6706627. 5: Kameoka H, Tsutsui I, Saito K, Kikuchi Y, Handa Y, Ezawa T, Hayashi H, Kawaguchi M, Akiyama K. Stimulation of asymbiotic sporulation in arbuscular mycorrhizal fungi by fatty acids. Nat Microbiol. 2019 Oct;4(10):1654-1660. doi: 10.1038/s41564-019-0485-7. Epub 2019 Jun 24. PMID: 31235957. 6: Nickels JD, Chatterjee S, Stanley CB, Qian S, Cheng X, Myles DAA, Standaert RF, Elkins JG, Katsaras J. The in vivo structure of biological membranes and evidence for lipid domains. PLoS Biol. 2017 May 23;15(5):e2002214. doi: 10.1371/journal.pbio.2002214. PMID: 28542493; PMCID: PMC5441578. 7: Inoue T, Shingaki R, Fukui K. Inhibition of swarming motility of Pseudomonas aeruginosa by branched-chain fatty acids. FEMS Microbiol Lett. 2008 Apr;281(1):81-6. doi: 10.1111/j.1574-6968.2008.01089.x. PMID: 18318842. 8: Thurnhofer S, Hottinger G, Vetter W. Enantioselective determination of anteiso fatty acids in food samples. Anal Chem. 2007 Jun 15;79(12):4696-701. doi: 10.1021/ac0702894. Epub 2007 May 18. PMID: 17508720. 9: GERSON T, SHORLAND FB, ADAMS Y, BELL ME. Further studies on the metabolism of the (plus)-anteiso-acids, (plus)-12-methyltetradecanoic acid and (plus)-14-methyl-hexadecanoic acid, in the rat. Biochem J. 1959 Dec;73(4):594-6. doi: 10.1042/bj0730594. PMID: 13827622; PMCID: PMC1197106. 10: HANSEN RP, SHORLAND FB, COOKE NJ. The branched-chain fatty acids of butterfat. 5. The isolation of 12-methyltridecanoic acid. Biochem J. 1954 Nov;58(3):358-9. doi: 10.1042/bj0580358. PMID: 13208621; PMCID: PMC1269905. 11: Lindström F, Thurnhofer S, Vetter W, Gröbner G. Impact on lipid membrane organization by free branched-chain fatty acids. Phys Chem Chem Phys. 2006 Nov 7;8(41):4792-7. doi: 10.1039/b607460j. Epub 2006 Sep 19. PMID: 17043723. 12: Colnaghi Simionato AV, da Silva DS, Lambais MR, Carrilho E. Characterization of a putative Xylella fastidiosa diffusible signal factor by HRGC-EI-MS. J Mass Spectrom. 2007 Apr;42(4):490-6. doi: 10.1002/jms.1181. PMID: 17295415. 13: Xu Y, Li H, Li X, Xiao X, Qian PY. Inhibitory effects of a branched-chain fatty acid on larval settlement of the polychaete Hydroides elegans. Mar Biotechnol (NY). 2009 Jul-Aug;11(4):495-504. doi: 10.1007/s10126-008-9161-2. Epub 2008 Nov 22. PMID: 19030931. 14: Cole N, Hume EB, Jalbert I, Vijay AK, Krishnan R, Willcox MD. Effects of topical administration of 12-methyl tetradecanoic acid (12-MTA) on the development of corneal angiogenesis. Angiogenesis. 2007;10(1):47-54. doi: 10.1007/s10456-007-9063-3. Epub 2007 Feb 13. PMID: 17295090. 15: HANSEN RP, SHORLAND FB, COOKE NJ. The branched-chain fatty acids of butterfat. IV. The isolation of (+)-12-methyltetradecanoic acid and of 13-methyltetradecanoic acid. Biochem J. 1954 Jun;57(2):297-301. doi: 10.1042/bj0570297. PMID: 13172183; PMCID: PMC1269745. 16: Inoue T, Kuroda T, Ohara N. 12-Methyltetradecanoic acid, a branched-chain fatty acid, represses the extracellular production of surfactants required for swarming motility in Pseudomonas aeruginosa PAO1. Jpn J Infect Dis. 2012;65(2):126-31. PMID: 22446119. 17: Edgcomb MR, Sirimanne S, Wilkinson BJ, Drouin P, Morse RD. Electron paramagnetic resonance studies of the membrane fluidity of the foodborne pathogenic psychrotroph Listeria monocytogenes. Biochim Biophys Acta. 2000 Jan 15;1463(1):31-42. doi: 10.1016/s0005-2736(99)00179-0. PMID: 10631292. 18: HANSEN RP, SHORLAND FB, COOKE NJ. The branched-chain fatty acids of mutton fat. II. The isolation of (+)-12-methyltetradecanoic acid and the 13-methyltetradecanoic acid. Biochem J. 1953 Feb;53(3):374-8. doi: 10.1042/bj0530374. PMID: 13032080; PMCID: PMC1198159. 19: Yang P, Collin P, Madden T, Chan D, Sweeney-Gotsch B, McConkey D, Newman RA. Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenase. Prostate. 2003 Jun 1;55(4):281-91. doi: 10.1002/pros.10243. PMID: 12712407. 20: Ramm W, Schatton W, Wagner-Döbler I, Wray V, Nimtz M, Tokuda H, Enjyo F, Nishino H, Beil W, Heckmann R, Lurtz V, Lang S. Diglucosyl-glycerolipids from the marine sponge-associated Bacillus pumilus strain AAS3: their production, enzymatic modification and properties. Appl Microbiol Biotechnol. 2004 May;64(4):497-504. doi: 10.1007/s00253-003-1471-8. Epub 2003 Oct 31. PMID: 14593508.